Latest Everolimus Stories
A new analysis may help doctors identify breast cancer patients who will benefit from treatment with the immune suppressant drug everolimus.
The combination of two inhibitors of protein mTOR stops the growth of primary liver cancer and destroys tumor cells.
Four proteins involved in translation, the final step of general protein production, are associated with poor prognosis in hormone-receptor-positive breast cancer when they are dysregulated.
- A woman chauffeur.
- A woman who operates an automobile.